Lacosamide Mylan

Lacosamide, the active ingredient in Lacosamide Mylan, is an anticonvulsant presented as a tablet for oral use. It treats partial‑onset seizures and epilepsy in patients who require seizure control.

GNH USA supplies Lacosamide Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacosamide is an anticonvulsant used in the management of seizure disorders.

Partial‑onset seizures: reduces the frequency and severity of focal seizures. Epilepsy: provides adjunctive therapy for patients with refractory epilepsy.

Lacosamide may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Nausea: mild gastrointestinal upset. - Fatigue: feeling unusually tired. - Headache: mild to moderate pain. - Tremor: involuntary shaking of limbs. - Diplopia: temporary double vision.

Serious or Rare Side Effects: - Cardiac arrhythmia: abnormal heart rhythm, especially PR‑interval prolongation. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Suicidal thoughts: emergence of depressive symptoms. - Hepatic dysfunction: elevated liver enzymes. - Allergic reaction: rash, swelling, or anaphylaxis.

Before prescribing Lacosamide, clinicians should consider several safety factors.

Cardiac monitoring: assess baseline ECG and monitor PR interval. Renal impairment: adjust use in patients with severe kidney dysfunction. Hepatic disease: evaluate liver function prior to initiation. Pregnancy and lactation: weigh potential risks as safety data are limited. Drug‑specific warnings: avoid abrupt discontinuation to reduce seizure recurrence. Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Lacosamide can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Strong CYP3A4 inducers: may reduce lacosamide plasma levels. - Concomitant class III anti‑arrhythmics: increase risk of cardiac conduction abnormalities.

Moderate Interactions (Monitor Closely): - Other antiepileptics (e.g., carbamazepine, phenytoin): may alter seizure control. - CNS depressants (e.g., benzodiazepines, opioids): may enhance sedation. - Alcohol: can increase dizziness and coordination problems.